| Jupiter Medical Center Physician Group | |
|
399 Tequesta Dr Suite 102 Tequesta FL 33469-3087 | |
| (561) 748-2889 | |
| (561) 748-1523 |
| Full Name | Jupiter Medical Center Physician Group |
|---|---|
| Speciality | Internal Medicine |
| Location | 399 Tequesta Dr, Tequesta, Florida |
| Authorized Official Name and Position | Karen Barlow (OWNER BILLING COMPANY) |
| Authorized Official Contact | 5617482889 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Jupiter Medical Center Physician Group Po Box 8850 Jupiter FL 33468-8850 Ph: (561) 748-2889 | Jupiter Medical Center Physician Group 399 Tequesta Dr Suite 102 Tequesta FL 33469-3087 Ph: (561) 748-2889 |
| NPI Number | 1629251277 |
|---|---|
| Provider Enumeration Date | 12/06/2007 |
| Last Update Date | 12/06/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629251277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME0044113 (Florida) | Primary |
News Archive
The work of researchers Francesc Viñals and Mariona Graupera at the Bellvitge Biomedical Research Institute - Catalan Institute of Oncology - University of Barcelona, together with Dr. Antoni Riera-Mestre, has led to a new potential treatment for Hereditary Hemorrhagic Telangiectasia or Rendu-Osler Syndrome, a rare disease that affects blood vessels and had no described treatment.
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.
Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that additional claims for the patent family "Internalizing anti-CD74 antibodies and methods of use," were issued as U.S. Patent No. 7,772,373. The new patent, which will expire in March 2023, covers any humanized antibodies that compete for binding to CD74 with milatuzumab, or bind to the same epitope as milatuzumab.
A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many researchers as the ideal way to replace cells lost in type I diabetes and to free patients from insulin injections.
› Verified 9 days ago
Tequesta Family Practice Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 395 B Tequesta Dr, Tequesta, FL 33458 Phone: 561-746-4333 Fax: 561-746-4449 | |
Forge Wellness Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr Ste 12e, Tequesta, FL 33469 Phone: 561-600-0194 Fax: 954-301-3742 | |
Best Medical Associates Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 364 Cypress Dr Ste 201, Tequesta, FL 33469 Phone: 561-578-8080 Fax: 973-755-0309 | |
Tequesta Health Center, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 12e, Tequesta, FL 33469 Phone: 561-747-7672 Fax: 561-743-3667 | |
Tequesta Family Medical Center, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 851 N Us Highway 1, Tequesta, FL 33469 Phone: 561-743-8362 | |
Primary Care Services Of Jupiter Medical Specialists, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 12e, Tequesta, FL 33469 Phone: 561-263-4477 |